Vical Incorporated · San Diego, CA United States (NASDAQ: VICL)
| 10390 Pacific Center Ct. | Phone: 858-646-1100 |
| San Diego, CA | Fax: 858-646-1150 |
| 92121 | |
| United States | 
Map This Company |
Vical Incorporated Rankings
More Companies in These Related Industries: Biologics MfgCompany Description
Vical counts DNA as its main ally in tackling disease. The biopharmaceutical company researches and develops vaccines based on its DNA delivery technology, which uses portions of the genetic code of a pathogen to induce an immune response. Vical has a number of drug candidates in its pipeline that it is developing independently and through corporate and government collaborations. Its pipeline is focused on infectious disease, cancer immunotherapies, and cardiovascular disease. Vical's lead candidate, being independently-developed, is Allovectin-7, an immunotherapy for metastatic melanoma (skin cancer).
Vical Incorporated Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: VICL Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 114 |
Executives
21 executives listed for Vical Incorporated's San Diego, CA location.
| Chairman | R. Gordon Douglas | |
|---|---|---|
| President, CEO, and Director | Vijay Samant | |
| SVP Business Operations | Robin Jackman |